TY - JOUR T1 - DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial. JO - J Thorac Oncol PY - 2006/11/01 AU - Payne M AU - Ellis P AU - Dunlop D AU - Ranson M AU - Danson S AU - Schacter L AU - Talbot D ED - VL - 1 IS - 9 SP - 984 EP - 990 Y2 - 2025/05/17 ER -